Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07080242
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:28.960159+00:00
Published At
2026-02-09T00:00:00+00:00
Record Updated At
2026-02-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Small Cell Lung Cancer Metastatic or Locally Advanced", "Neuroendocrine Cancer", "Metastatic or Locally Advanced Neuroendocrine Prostate Cancer", "Metastatic or Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma", "Metastatic or Locally Advanced Merkel Cell Carcinoma", "Locally Advanced or Metastatic Large Cell Neuroendocrine Carcinoma of the Lung", "Metastatic or Locally Advanced Extrapulmonary Neuroendocrine Carcinoma", "Poorly Differentiated and/or High Grade Neuroendocrine Neoplasms With Evidence of DLL3 Expression"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-09"
protocolSection.identificationModule.nctId
"NCT07080242"
protocolSection.identificationModule.officialTitle
"A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Small Cell Lung Cancer Metastatic or Locally Advanced (protocolSection.conditionsModule.conditions)
  • Neuroendocrine Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic or Locally Advanced Neuroendocrine Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic or Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic or Locally Advanced Merkel Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Locally Advanced or Metastatic Large Cell Neuroendocrine Carcinoma of the Lung (protocolSection.conditionsModule.conditions)
  • Metastatic or Locally Advanced Extrapulmonary Neuroendocrine Carcinoma (protocolSection.conditionsModule.conditions)
  • Poorly Differentiated and/or High Grade Neuroendocrine Neoplasms With Evidence of DLL3 Expression (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.